The MST Access Equity Research Report, available on the Recce website, gives estimates of the likely pricing of treatments arising from successful trials. Estimates of US$500 per burns treatment and US$5,000 per IV sepsis treatment were benchmarked to pricing for existing inpatient antibiotic uses.
An extract from the Report below gives details. The comment underneath the table is interesting.
RCE Price at posting:
78.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)